medline.ch Onkologie Urologische Tumoren

	Do patterns of perineural invasion improve risk stratification in prostate cancer? A narrative review. Histol Histopathol Miyamoto H. PMID: 41823190 [PubMed - as supplied by publisher]
	Diagnostic accuracy and reliability of VI-RADS in assessing muscle invasion in bladder cancer: Insight from a prospective tertiary care study. Urologia Shukla A, Hiralal, Raj H, Surekha S, Singh UP. PMID: 41823129 [PubMed - as supplied by publisher]
	A narrative review of the current state of circulating tumor cells in prostate cancer diagnostic. Hell Urol Vovdenko S, Bazarkin A, Morozov A, Golan S, Babaevskaya D, Singla N, Baniel J, Brill B, Moreno Sierra J, Gomez Rivas J, Enikeev D. PMID: 41822810 [PubMed]
	Kidney-Sparing Approaches in Upper Tract Urothelial Cancer: A Narrative Review. Cureus Kefalas C, Datseris N, Sitaridis K, Mourtzilas E, Papalakis A. PMID: 41822654 [PubMed]
	Application of carbonic anhydrase IX-targeted radiopharmaceuticals in the diagnosis and treatment of clear cell renal cell carcinoma (Review). Oncol Lett Wang M, Li Y, Yang W, Liu B. PMID: 41822559 [PubMed]
	Deep learning-based detection and segmentation of osseous metastatic prostate cancer lesions on computed tomography. Eur J Radiol Artif Intell Pawan SJ, Rich JM, Malewar S, Patel D, Muellner M, Hwang D, Lei X, Cen S, Triche T, Goldkorn A, Mohamed P, Oberai A, Duddalwar V. PMID: 41822381 [PubMed]
	Functional and Survival Outcomes of Partial Versus Radical Nephrectomy in Renal Cell Carcinoma Patients With Pre-Existing Chronic Kidney Disease: A Real-World Study. World J Oncol Thai LK, Luu VQ, Thai SM. PMID: 41822317 [PubMed]
	Muscle size and muscle fat infiltration in patients with newly diagnosed prostate cancer: a case-control study. Front Oncol Wang C, Wang H, Yu Y, Yang X, Wang Y, Zhang K, Sun S, Wu L, Fang D, Li H, Yang Y, Chen X, Bi S, Wen H. PMID: 41821899 [PubMed]
	Body mass index and prostate cancer incidence: a comprehensive systematic review. Front Oncol Myers D, Chissum Lagos D, Zapata I, Hwang C. PMID: 41821886 [PubMed]
	The prognostic impact of systemic inflammation and nutritional indicators on targeted therapy for renal cell carcinoma: a systematic review and meta-analysis. Front Nutr Xiao Y, Dai Y, Zhong X, Zhang L, Xie R, Zhou Q, Liang W, Sun X, Yang M, Zou Z, Wang Y, Li H, Niu T. PMID: 41821864 [PubMed]
	Disulfidptosis and androgenic cancers: from molecular mechanisms to clinical applications and future translational research. Front Endocrinol (Lausanne) Wang X, Zhao J, Li Q, Chang J, Zhao W, Xing X. PMID: 41821736 [PubMed - indexed for MEDLINE]
	Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma. Ann Med He DL, Zhu FF, Wang J, Zhu SW, Hou SS. PMID: 41821478 [PubMed - indexed for MEDLINE]
	Comparison between artificial intelligence-based and manual organ delineations in pretreatment computed tomography scans of prostate cancer patients: a visual grading study. Radiat Prot Dosimetry Polymeri E, Johnsson ÅA, Enqvist O, Ulén J, Kindblom J, Braide K, Wiltz HJ, Tanyasiová M, Trägårdh E, Edenbrandt L, Kjölhede H, Svalkvist A. PMID: 41821468 [PubMed - indexed for MEDLINE]
	Does Insulin Resistance Predict Lower Urinary Tract Symptoms? Results From the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. Prostate Zheng R, Daniels JP, Mirocha JM, Hernández-Tirado A, Moreira DM, Fowke JH, Freedland SJ. PMID: 41821360 [PubMed - as supplied by publisher]
	Conditional Relative Survival and Competing Mortality in Surgically Treated Patients with Localized and Regional Kidney Cancer in Korea: A Nationwide Cohort Study. Cancer Res Treat Shin HB, Shin DW, Cho IY, Park J, Hyung JJ, Han K, Park J. PMID: 41821141 [PubMed - as supplied by publisher]
	Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study. Cancer Med Cortes-Mejia N, Wong R, Eltzschig HK, Moreno-Lopez SM, Bejarano-Ramirez D, Huang H, Cata JP. PMID: 41820815 [PubMed - indexed for MEDLINE]
	Foundation Model and Multi-Instance Learning-Based Framework for Predicting Lymphovascular Invasion in Prostate Cancer. Ann Surg Oncol Zheng Q, Mei H, Wang D, Liu X, Wang L, Chen Z. PMID: 41820759 [PubMed - as supplied by publisher]
	An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORÎ³/RORÎ³t Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer. Eur Urol Oncol Grochot R, Guo C, Carreira S, Crespo M, Welti J, Miranda S, Figueiredo I, Bertan C, Rekowski J, Yuan W, Tunariu N, Abramowicz K, Ferreira A, Riisnaes R, Neeb A, Gurel B, Fenor de la Maza MLD, Chandran K, Carmichael J, Westaby D, Kohlhof H, Sharp A, Paschalis A, de Bono J. PMID: 41820163 [PubMed - as supplied by publisher]
	Intraductal histiocytes as a simulant of intraductal carcinoma of the prostate. Am J Clin Pathol Wobker SE, Williamson SR, Kenigsberg A, Muthusamy S, Smith SC. PMID: 41819611 [PubMed - indexed for MEDLINE]
	Patient-reported psychological and prostate cancer-specific functional outcomes among men with low-risk prostate cancer two years after diagnosis: The PREPARE prospective cohort study. Urology Davis KM, Luta G, Hoffman RM, Lobo T, Zotou V, Potosky AL, Sanda MG, Penson D, Khosrow-Khavar F, Ergas IJ, Van Den Eeden SK, Taylor KL. PMID: 41819414 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 176772

Seite 1 von 8839

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung